Alaxia and Stragen launch partnership to speed up development of new treatment for Cystic Fibrosis

Wed, 01/25/2012

Lyon, 26th January 2012 – The Swiss pharmaceutical group Stragen and the French Lyon-based start-up Alaxia today announced they have signed a partnership agreement to support the development of the drug candidate Meveol® until registration
  
Click here to read the press release. 

   
  
  

Development of a treatment to fight against Cystic Fibrosis
The regulatory preclinical study was co-financed by E.U. Europe is moving in Rhone Alpes with the European Regional Development Fund.